The Conversation (0)
Chart
Detailed Quote
Zealand Pharma is a biotechnology company. It is focused on the discovery, design and development of peptide-based medicines. Its products include soliqua 100/33/suliqua and adlyxin. The firm focuses on gastrointestinal diseases and metabolic diseases. Its product pipeline includes dasiglucagon, glepaglutide and dual glucagon product candidates.
Featured Articles and Interviews
Oct 23, 2025
Biotech and Pharma Market Update: Q3 2025 in Review
Apr 16, 2024
Biotech Market Update: Q1 2024 in Review
Press Releases
See More Press Releases
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.
